[go: up one dir, main page]

DE60121431D1 - Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe - Google Patents

Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe

Info

Publication number
DE60121431D1
DE60121431D1 DE60121431T DE60121431T DE60121431D1 DE 60121431 D1 DE60121431 D1 DE 60121431D1 DE 60121431 T DE60121431 T DE 60121431T DE 60121431 T DE60121431 T DE 60121431T DE 60121431 D1 DE60121431 D1 DE 60121431D1
Authority
DE
Germany
Prior art keywords
pyridine
implementation
active substances
oxide
pharmaceutical active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121431T
Other languages
English (en)
Other versions
DE60121431T2 (de
Inventor
Laszlo Ueroegdi
Lajos Gruber
Laszlo Oetvoes
Juzsef Toth
Istvan Toemoeskoezi
Schmidt Aniku Szakacsne
Ferencne Reider
Barlay Maria Schneiderne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LadRx Corp
Original Assignee
Biorex Kutato Fejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejleszto Kft filed Critical Biorex Kutato Fejleszto Kft
Publication of DE60121431D1 publication Critical patent/DE60121431D1/de
Application granted granted Critical
Publication of DE60121431T2 publication Critical patent/DE60121431T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60121431T 2000-04-18 2001-04-17 Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe Expired - Lifetime DE60121431T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0001583A HUP0001583A2 (hu) 2000-04-18 2000-04-18 Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
HU0001583 2000-04-18
PCT/HU2001/000046 WO2001079174A1 (en) 2000-04-18 2001-04-17 A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds

Publications (2)

Publication Number Publication Date
DE60121431D1 true DE60121431D1 (de) 2006-08-24
DE60121431T2 DE60121431T2 (de) 2007-01-18

Family

ID=90001563

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121431T Expired - Lifetime DE60121431T2 (de) 2000-04-18 2001-04-17 Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe

Country Status (31)

Country Link
US (1) US7126002B2 (de)
EP (1) EP1274685B1 (de)
JP (1) JP5066638B2 (de)
KR (1) KR100742482B1 (de)
CN (1) CN1216868C (de)
AT (1) ATE332894T1 (de)
AU (2) AU2001254997B2 (de)
BG (1) BG65889B1 (de)
BR (1) BRPI0110184B8 (de)
CA (1) CA2406266C (de)
CY (1) CY1107473T1 (de)
CZ (1) CZ301576B6 (de)
DE (1) DE60121431T2 (de)
DK (1) DK1274685T3 (de)
EE (1) EE05085B1 (de)
ES (1) ES2267758T3 (de)
HR (1) HRP20020825A2 (de)
HU (1) HUP0001583A2 (de)
IL (2) IL152337A0 (de)
MX (1) MXPA02010320A (de)
NO (1) NO323535B1 (de)
NZ (1) NZ522017A (de)
PL (1) PL359826A1 (de)
PT (1) PT1274685E (de)
RS (1) RS51003B (de)
RU (1) RU2281282C2 (de)
SI (1) SI1274685T1 (de)
SK (1) SK287606B6 (de)
UA (1) UA75353C2 (de)
WO (1) WO2001079174A1 (de)
ZA (1) ZA200208460B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
HU0103939D0 (en) * 2001-09-27 2001-11-28 Biorex Kutato Fejlesztoe Kft Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
MXPA04006716A (es) * 2002-01-11 2004-11-10 Biorex Kutato Es Rejleszt Rt Derivados de carboxamidina y su uso en el tratamiento de enfermedades vasculares.
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
TW200831479A (en) * 2006-09-26 2008-08-01 Cytrx Corp Pharmaceutical compositions and methods for treating diseases
DK2318032T3 (da) 2008-06-26 2012-06-11 Orphazyme Aps Anvendelse af Hsp70 som regulator af enzymatisk aktivitet
US9662375B2 (en) 2010-11-30 2017-05-30 Orphazyme Aps Methods for increasing intracellular activity of Hsp70
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
CN107106494B (zh) 2014-09-15 2021-12-21 奥菲泽米有限公司 阿瑞洛莫制剂
US10898476B2 (en) 2016-04-13 2021-01-26 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
HRP20210047T1 (hr) 2016-04-29 2021-04-16 Orphazyme A/S, c/o COBIS A/S Arimoclomol za liječenje poremećaja povezanih s glukocerebrozidazom
BR112020005732A2 (pt) 2017-09-22 2020-10-27 The University Of Adelaide métodos e produtos para melhorar a qualidade de espermatozoides
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
IL299250A (en) 2020-06-24 2023-02-01 Kempharm Denmark As Arimoclomol for the treatment of Gaucher disease
KR20230128462A (ko) * 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정
CN116783164A (zh) * 2020-11-19 2023-09-19 泽维拉丹麦股份有限公司 制备柠檬酸阿瑞洛莫及其中间体的方法
MX2023007551A (es) 2020-12-24 2023-09-04 Zevra Denmark As Arimoclomol para el tratamiento de la enfermedad de niemann pick, tipo c, en pacientes con mutaciones de sentido erroneo de tipo reticulo endoplasmatico (er).
AU2023454616A1 (en) 2023-07-10 2026-01-22 N-Gene Research Laboratories, Inc. Increasing telomere length and/or suppressing telomere shortening

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component

Also Published As

Publication number Publication date
RU2281282C2 (ru) 2006-08-10
KR100742482B1 (ko) 2007-07-25
AU5499701A (en) 2001-10-30
BR0110184A (pt) 2003-06-17
BG107199A (bg) 2003-07-31
HK1055741A1 (en) 2004-01-21
WO2001079174A1 (en) 2001-10-25
EE200200591A (et) 2004-04-15
CN1434800A (zh) 2003-08-06
KR20030011309A (ko) 2003-02-07
IL152337A0 (en) 2003-05-29
EP1274685A1 (de) 2003-01-15
RS51003B (sr) 2010-10-31
HUP0001583D0 (en) 2000-06-28
US7126002B2 (en) 2006-10-24
BRPI0110184B1 (pt) 2015-12-29
WO2001079174A8 (en) 2002-12-27
PL359826A1 (en) 2004-09-06
CY1107473T1 (el) 2012-12-19
CZ20023445A3 (cs) 2003-03-12
UA75353C2 (en) 2006-04-17
DK1274685T3 (da) 2006-11-06
BRPI0110184B8 (pt) 2021-05-25
SI1274685T1 (sl) 2006-10-31
US20040006232A1 (en) 2004-01-08
RU2002130710A (ru) 2004-03-20
PT1274685E (pt) 2006-09-29
DE60121431T2 (de) 2007-01-18
CA2406266C (en) 2010-07-20
MXPA02010320A (es) 2004-09-06
HUP0001583A2 (hu) 2002-11-28
JP5066638B2 (ja) 2012-11-07
ATE332894T1 (de) 2006-08-15
ES2267758T3 (es) 2007-03-16
NO20025015L (no) 2002-12-16
JP2004501080A (ja) 2004-01-15
HRP20020825A2 (en) 2004-12-31
SK287606B6 (sk) 2011-03-04
IL152337A (en) 2007-10-31
EP1274685B1 (de) 2006-07-12
EE05085B1 (et) 2008-10-15
BG65889B1 (bg) 2010-04-30
ZA200208460B (en) 2003-10-20
CN1216868C (zh) 2005-08-31
SK15082002A3 (sk) 2003-05-02
NO323535B1 (no) 2007-06-04
AU2001254997B2 (en) 2006-11-23
NO20025015D0 (no) 2002-10-18
YU78302A (sh) 2005-09-19
NZ522017A (en) 2004-06-25
CA2406266A1 (en) 2001-10-25
CZ301576B6 (cs) 2010-04-21

Similar Documents

Publication Publication Date Title
DE60121431D1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
SE9904505D0 (sv) Novel compounds
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
BR0016543A (pt) Novos derivados de piperidina e piperazina
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
SE9704545D0 (sv) Novel compounds
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
ATE386725T1 (de) Heterocyclylverbindungen
GEP20002187B (en) Carboxamide Derivatives of Pyrrolidine, Piperidine and Hexahydroazepine, Composition for the Treatment of Thrombosis Disorders Induced by Thrombocytes, Intermediate Compounds and Method for Their Preparation
NO20020282D0 (no) Nytt difenylpiperidinderivat
EP1379508A4 (de) N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen
DK1194415T3 (da) Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
FR2842524B1 (fr) Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments
ATE236885T1 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
UA81610C2 (ru) Изохинолиновые соединения, способ их получения и фармацевтическая композиция, которая их содержит
DE69905490D1 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
EA200200491A1 (ru) Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцины и их применение в качестве лекарственных средств
NO20021527L (no) Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel
NO20063353L (no) 1,2,3,4-tetrahydroisokinolinderivater, fremgangsmate for fremstilling derav og anvendelser derav
SE9803277D0 (sv) Novel compounds
ATE402178T1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten
SE9704835D0 (sv) New compound

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: CYTRX CORP., LOS ANGELES, CALIF., US

8364 No opposition during term of opposition